Long-Term Safety in HBsAg-Negative, HBcAb-Positive Patients with Rheumatic Diseases Receiving Maintained Steroid Therapy after Pulse Therapy

Long-Term Safety in HBsAg-Negative, HBcAb-Positive Patients with Rheumatic Diseases Receiving Maintained Steroid Therapy after Pulse Therapy

The risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen (HBsAg)-negative, antibody to hepatitis B core antigen (anti-HBc)-positive patients after glucocorticoid (GC) pulse therapy remains unclear. Aims: Our study aimed to examine the safety of GC pulse therapy in HBsAg-negati...

Full description

Bibliographic Details
Main Authors: Ying-Cheng Lin, Yen-Ju Chen, Shou-Wu Lee, Teng-Yu Lee, Yi-Hsing Chen, Wen-Nan Huang, Sheng-Shun Yang, Yi-Ming Chen
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Journal of Clinical Medicine
Subjects:
glucocorticoid pulse therapy
hepatitis B surface antigen
seroreversion
rheumatic diseases
Online Access:https://www.mdpi.com/2077-0383/10/15/3296

Internet

https://www.mdpi.com/2077-0383/10/15/3296

Similar Items